Healthcare Tech Deal Falls Foul of UK CMA’s Harder Line on Merger Control

    View Author May 2021

    There has been yet another UK Competition and Markets Authority (CMA) merger referral for in-depth investigation, this time in the healthcare sector confirming the CMA’s willingness “to ensure that the NHS does not pay significantly more than it should” for products and services. The merging parties, Imprivata and Isosec, provide similar identity and access management (IAM) solutions that allow staff of healthcare customers (including NHS entities) to access sensitive patient data – in particular, that gives them access to NHS Spine (the IT infrastructure for health and social care in England).

    This publication addresses the CMA’s referral decision which is reflective of a broader hardening of UK merger control enforcement and looks at three important aspects of interest for healthcare tech companies.